ONO-5334
Product Specifications
UNSPSC Description
ONO-5334 is a potent, selective and orally active cathepsin K inhibitor with Ki values of 0.10 nM, 0.049 nM and 0.85 nM for human, rabbit and rat cathepsin K, respectively. ONO 5334 is an effective antiviral compound against SAR-COV-2 virus activity with an EC50 value of 500 nM. ONO-5334 has the potential for the study of osteoporosis and COVID-19 disease[1].
Target Antigen
Cathepsin; SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection;Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ono-5334.html
Purity
99.83
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C(N/N=C(SC[C@H]1C)/N1C)=O)[C@H](C2CCOCC2)NC(C3CCCCCC3)=O
Molecular Weight
438.58
References & Citations
[1]Ochi Y, et al. Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism. Bone. 2011 Dec;49(6):1351-6.|[2]Laura Riva, et al.A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals. bioRxiv. 2020 Apr 17;2020.04.16.044016.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-108044/ONO-5334-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-108044/ONO-5334-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
868273-90-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1025855-01 1 mg (E-Coli)
Recombinant Gramella forsetii UPF0391 membrane protein GFO_1615 (GFO_1615), partial
Ask
View Details MBS1025855-02 1 mg (Yeast)
Recombinant Gramella forsetii UPF0391 membrane protein GFO_1615 (GFO_1615), partial
Ask
View Details 
RC203605L1V 200 µL
HSPC302 (TBCK) (NM_033115) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details